Neuro-urological assessment and treatment
Authors:
M. Drake 1; F. Cruz 2
Authors place of work:
University of Bristol, Bristol Urological Institute Southmead Hospital, Bristol, UK
1; Department of Urology, Hospital São João, Portugal
2
Published in the journal:
Urol List 2011; 9(1): 32-37
Summary
Neurourology is a specialised area requiring considerable resources and expertise. The primary concern for patient management is to ensure preventable health threats are identified, including risk factors for renal deterioration, latex allergy and autonomic dysreflexia. Lower urinary tract symptoms are common, and various options are available to improve either storage or voiding. All options carry potential adverse effects and have to be evaluated carefully in the context of the individual’s remaining function, such as mobility, manual dexterity and cognitive function.
Key words:
neurourology, neurogenic incontinence, detrusor sphincter dyssynergia, autonomic dysreflexia
Zdroje
1. Abrams P, Andersson KE, Birder L et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29(1): 213–240.
2. Stohrer M, Blok B, Castro-Diaz D et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 2009; 56(1): 81–88.
3. Fowler CJ, Panicker JN, Drake M et al. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80(5): 470–477.
4. Ruffion A, de Seze M, Denys P et al. Groupe d'Etudes de Neuro-Urologie de Langue Francaise (GENULF) guidelines for the management of spinal cord injury and spina bifida patients. Prog Urol 2007; 17(3): 631–633.
5. Linsenmeyer TA, Oakley A. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med 2003; 26(4): 352–357.
6. de Seze M, Ruffion A, Denys P et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007; 13(7): 915–928.
7. Drake MJ, Cortina-Borja M, Savic G et al. Prospective evaluation of urological effects of aging in chronic spinal cord injury by method of bladder management. Neurourol Urodyn 2005; 24(2): 111–116.
8. Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21(3): 261–274.
9. Ghoniem GM, Bloom DA, McGuire EJ et al. Bladder compliance in meningomyelocele children. J Urol 1989; 141(6): 1404–1406.
10. Geirsson G, Lindstrom S, Fall M. Pressure, volume and infusion speed criteria for the ice-water test. Br
J Urol 1994; 73(5): 498–503.
11. Khastgir J, Drake MJ, Abrams P. Recognition and effective management of autonomic dysreflexia in spinal cord injuries. Expert Opin Pharmacother 2007; 8(7): 945–956.
12. Ozkaya E, Coskun Y, Turkmenoglu Y et al. Prevalance of latex sensitization and associated risk factors in Turkish children with spina bifida. Pediatr Surg Int 2010; 26(5): 535–538.
13. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol 2002; 110 (2 Suppl): S64–69.
14. Jamison J, Maguire S, McCann J. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev 2004; (2): CD004375.
15. Schlager TA, Clark M, Anderson S. Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catheterization for bladder emptying. Pediatrics 2001; 108(4): E71.
16. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology 2002; 59(2): 240–244.
17. Giannantoni A, Mearini E, Del Zingaro M et al. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application. BJU Int 2008; 102 (Suppl 1): 2–6.
18. Apostolidis A, Dasgupta P, Denys P et al. Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report. Eur Urol 2008; 55(1): 100–119.
19. Schurch B. Bladder dysfunction after spinal and peripheral nerve lesions. Ther Umsch 2000; 57(11): 690–697.
20. Reitz A, Stohrer M, Kramer G et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45(4): 510–515.
21. Chancellor MB, Erhard MJ, Hirsch IH et al.
Prospective evaluation of terazosin for the treat-
ment of autonomic dysreflexia. J Urol 1994; 151(1): 111–113.
22. Safari S, Jamali S, Habibollahi P et al. Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods. Urology 2010; 76(1): 225–230.
23. Karsenty G, Baazeem A, Elzayat E et al. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results. Can J Urol 2006; 13(2): 3027–3033.
24. Ahmed HU, Shergill IS, Arya M et al. Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol 2006; 3(7): 368–380.
25. Pan D, Troy A, Rogerson J et al. Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 2009; 181(2): 705–709.
26. Abdul-Rahman A, Ismail S, Hamid R et al. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU Int 2010; 106(10): 1510–1513.
27. Bramble FJ. The clam cystoplasty. Br J Urol 1990; 66(4): 337–341.
28. Hasan ST, Marshall C, Robson WA et al. Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. Br J Urol 1995; 76(5): 551–557.
29. Cartwright PC, Snow BW. Bladder autoaugmentation: partial detrusor excision to augment the
bladder without use of bowel. J Urol 1989; 142(4): 1050–1053.
30. Kastler EC, Genevois S, Gamé X et al. Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre study. BJU Int 2011; 107(3): 426–432.
31. Vignes JR, Bauchet L, Ohanna F. Dorsal rhizotomy combined with anterior sacral root stimulation for neurogenic bladder. Acta Neurochir Suppl 2007; 97 (Pt 1): 323–331.
32. Ninkovic M, Stenzl A, Schwabegger A et al. Free neurovascular transfer of latisstmus dorsi muscle for the treatment of bladder acontractility: II. Clinical results. J Urol 2003; 169(4): 1379–1383.
33. Xiao CG. Reinnervation for neurogenic bladder: historic review and introduction of a somatic-autonomic reflex pathway procedure for patients with spinal cord injury or spina bifida. Eur Urol 2006; 49(1): 22–28; discussion 28–29.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2011 Číslo 1
Najčítanejšie v tomto čísle
- Management of urethral stricture: dorsal flap from buccal mucosa – the gold standard
- Urinary tract and genital trauma
- Hormone therapy in the management of prostate cancer: treating the cancer without hurting the patient
- Neuro-urological assessment and treatment